Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bock

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2017
Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South AfricaPeter Bock, Karen Jennings, Redwaan Vermaak, et al.
Plos One|December 17, 2021
Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART)Wendy Grant-McAuley, Ethan Klock, Oliver Laeyendecker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2020
HIV Stigma and Viral Suppression Among People Living With HIV in the Context of Universal Test and Treat: Analysis of Data From the HPTN 071 (PopART) Trial in Zambia and South AfricaJames R Hargreaves, Triantafyllos Pliakas, Graeme Hoddinott, et al.
Human Resources for Health|July 8, 2024
Prevalence and risk of burnout among HIV service providers in South Africa and Zambia: findings from the HPTN 071 (PopART) trialMara C Steinhaus, Tamaryn J Nicholson, Triantafyllos Pliakas, et al.
The Lancet. HIV|November 4, 2022
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysisDavid Macleod, Kwame Shanaube, Timothy Skalland, et al.
Journal of the International AIDS Society|July 1, 2022
HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART)Jessica M Fogel, Ethan A Wilson, Estelle Piwowar-Manning, et al.
AIDS and Behavior|November 12, 2018
Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South AfricaJanet Seeley, Virginia Bond, Blia Yang, et al.
Scientific Reports|June 4, 2024
Associations between HIV stigma and health-related quality-of-life among people living with HIV: cross-sectional analysis of data from HPTN 071 (PopART)Emily Hall, Katherine Davis, Julius Ohrnberger, et al.
Journal of the International AIDS Society|February 20, 2020
Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART)Susan H Eshleman, Estelle Piwowar-Manning, Ethan A Wilson, et al.
BMC Infectious Diseases|November 11, 2022
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatmentWendy Grant-McAuley, Oliver Laeyendecker, Daniel Monaco, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2017
Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South AfricaPeter Bock, Karen Jennings, Redwaan Vermaak, et al.
Plos One|December 17, 2021
Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART)Wendy Grant-McAuley, Ethan Klock, Oliver Laeyendecker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2020
HIV Stigma and Viral Suppression Among People Living With HIV in the Context of Universal Test and Treat: Analysis of Data From the HPTN 071 (PopART) Trial in Zambia and South AfricaJames R Hargreaves, Triantafyllos Pliakas, Graeme Hoddinott, et al.
Human Resources for Health|July 8, 2024
Prevalence and risk of burnout among HIV service providers in South Africa and Zambia: findings from the HPTN 071 (PopART) trialMara C Steinhaus, Tamaryn J Nicholson, Triantafyllos Pliakas, et al.
The Lancet. HIV|November 4, 2022
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysisDavid Macleod, Kwame Shanaube, Timothy Skalland, et al.
Journal of the International AIDS Society|July 1, 2022
HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART)Jessica M Fogel, Ethan A Wilson, Estelle Piwowar-Manning, et al.
AIDS and Behavior|November 12, 2018
Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South AfricaJanet Seeley, Virginia Bond, Blia Yang, et al.
Scientific Reports|June 4, 2024
Associations between HIV stigma and health-related quality-of-life among people living with HIV: cross-sectional analysis of data from HPTN 071 (PopART)Emily Hall, Katherine Davis, Julius Ohrnberger, et al.
Journal of the International AIDS Society|February 20, 2020
Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART)Susan H Eshleman, Estelle Piwowar-Manning, Ethan A Wilson, et al.
BMC Infectious Diseases|November 11, 2022
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatmentWendy Grant-McAuley, Oliver Laeyendecker, Daniel Monaco, et al.
Pageof 11